Join to View Full Profile
2025 Morse AveSacramento, CA 95825
Phone+1 916-973-5000
Dr. Lallana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Enrico Lallana is a neurologist specializing in neuro-oncology based in Sacramento, CA. He completed his medical education at the University of the East College of Medicine and trained at several prestigious institutions, including Montefiore Medical Center, University of Texas Southwestern Medical Center, and Memorial Sloan Kettering Cancer Center. He currently serves as an attending neuro-oncologist at Kaiser Permanente Sacramento Medical Center and previously held a position as Assistant Professor of Medicine and Neurology at Dartmouth-Hitchcock Medical Center. Dr. Lallana has contributed significantly to the field with multiple publications in renowned journals such as the Journal of Clinical Oncology and Cancer Discovery, focusing on treatments for astrocytoma, CNS lymphoma, and glioblastoma.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2002 - 2004
University of Texas Southwestern Medical CenterResidency, Neurology, 1999 - 2002
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 1998 - 1999
University of the East College of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2011 - 2027
NH State Medical License 2003 - 2012
American Board of Psychiatry and Neurology Neurology
United Council for Neurologic SubspecialtiesNeuro-Oncology
Publications & Presentations
PubMed
- STELLAR: Phase III, Randomized, Open-Label Study of Eflornithine Plus Lomustine Versus Lomustine Alone in Patients With Recurrent Grade 3 Astrocytoma.Howard Colman, Giuseppe Lombardi, Eric T Wong, Tobias Walbert, Marica Eoli
Journal of Clinical Oncology. 2025-12-01 - Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma.Antonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, Denise Correa, Jeffrey S Wefel
Neuro-Oncology. 2025-11-04 - 117 citationsNRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.Christina I Tsien, Stephanie L Pugh, Adam P Dicker, Jeffrey J Raizer, Martha M Matuszak
Journal of Clinical Oncology. 2023-02-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
